Sona Nanotech Selects Minnetronix to Engineer Its Next Generation Targeted Hypothermia Cancer Therapy Light Device

Sona Nanotech has partnered with Minnetronix Medical to engineer the second generation of its infrared light device for developing pre-clinical Targeted Hyperthermia Therapy for colorectal cancer. The light device will transfer energy by way of infrared light to Sona’s proprietary, biocompatible gold nanorods in cancerous tumors which will then convert the light energy into heat. The device is b..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 19.
  • textsms

Parthenon Therapeutics Announces Publication in Journal for ImmunoTherapy of Cancer on the Role of Immune Exclusion in Cancer

Precision oncology company Parthenon Therapeutics has had an article published in the Journal for ImmunoTherapy of Cancer (JITC) that identified key characteristics and issues relevant to the role immune exclusion plays in resistance to checkpoint therapy. The work was performed in collaboration with multiple US and international academic institutions. Parthenon recently initiated a Phase 1 tria..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 13.
  • textsms